chr12-53424443-C-G

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_020547.3(AMHR2):​c.205C>G​(p.Gln69Glu) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

AMHR2
NM_020547.3 missense

Scores

6
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.86
Variant links:
Genes affected
AMHR2 (HGNC:465): (anti-Mullerian hormone receptor type 2) This gene encodes the receptor for the anti-Mullerian hormone (AMH) which, in addition to testosterone, results in male sex differentiation. AMH and testosterone are produced in the testes by different cells and have different effects. Testosterone promotes the development of male genitalia while the binding of AMH to the encoded receptor prevents the development of the mullerian ducts into uterus and Fallopian tubes. Mutations in this gene are associated with persistent Mullerian duct syndrome type II. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.2371288).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
AMHR2NM_020547.3 linkuse as main transcriptc.205C>G p.Gln69Glu missense_variant 2/11 ENST00000257863.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
AMHR2ENST00000257863.9 linkuse as main transcriptc.205C>G p.Gln69Glu missense_variant 2/111 NM_020547.3 P1Q16671-1
AMHR2ENST00000379791.7 linkuse as main transcriptc.205C>G p.Gln69Glu missense_variant 2/91 Q16671-3
AMHR2ENST00000550311.5 linkuse as main transcriptc.205C>G p.Gln69Glu missense_variant 2/111 Q16671-2
AMHR2ENST00000553037.1 linkuse as main transcriptn.166C>G non_coding_transcript_exon_variant 1/24

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
32
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpAug 13, 2022In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with AMHR2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glutamine, which is neutral and polar, with glutamic acid, which is acidic and polar, at codon 69 of the AMHR2 protein (p.Gln69Glu). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Uncertain
0.099
D
BayesDel_noAF
Benign
-0.10
CADD
Benign
22
DANN
Benign
0.96
DEOGEN2
Uncertain
0.53
D;.;.
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.057
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Benign
0.80
T;T;T
M_CAP
Benign
0.057
D
MetaRNN
Benign
0.24
T;T;T
MetaSVM
Uncertain
0.054
D
MutationAssessor
Benign
0.81
L;L;L
MutationTaster
Benign
0.97
N;N;N
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-0.40
N;N;N
REVEL
Uncertain
0.30
Sift
Benign
0.23
T;T;T
Sift4G
Uncertain
0.057
T;D;D
Polyphen
0.26
B;.;.
Vest4
0.38
MutPred
0.38
Gain of catalytic residue at N66 (P = 0.0283);Gain of catalytic residue at N66 (P = 0.0283);Gain of catalytic residue at N66 (P = 0.0283);
MVP
0.97
MPC
0.11
ClinPred
0.43
T
GERP RS
4.2
Varity_R
0.17
gMVP
0.18

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs115737603; hg19: chr12-53818227; API